Elite Pharmaceuticals Inc (ELTP)

[Hike]

See a pattern here?

Novartis:
Novartis announces that researchers can now request access to patient level data on newly approved innovative medicines in the United States and EU in 2014 through the ideaPoint portal...

GSK:
When studies are listed After the medicine studied has been approved by regulators (first approval) or terminated from development all indications) and the study has been accepted for publication.

Bayer:
Studies are considered for inclusion in the “Study list” (see section “Studies listed”) after regulatory approval. In case of planned scientific publications, studies will be listed once the primary manuscript describing the results has been accepted for publication.

LOL LOL